Search Results - "Phelan, C M"

Refine Results
  1. 1

    Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study by Phelan, C M, Iqbal, J, Lynch, H T, Lubinski, J, Gronwald, J, Moller, P, Ghadirian, P, Foulkes, W D, Armel, S, Eisen, A, Neuhausen, S L, Senter, L, Singer, C F, Ainsworth, P, Kim-Sing, C, Tung, N, Llacuachaqui, M, Chornokur, G, Ping, S, Narod, S A

    Published in British journal of cancer (21-01-2014)
    “…Background: The BRCA1 and BRCA2 genes confer increased susceptibility to breast and ovarian cancer and to a spectrum of other cancers. There is controversy…”
    Get full text
    Journal Article
  2. 2

    Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms by Wilson, H L, Wong, A C C, Shaw, S R, Tse, W-Y, Stapleton, G A, Phelan, M C, Hu, S, Marshall, J, McDermid, H E

    Published in Journal of medical genetics (01-08-2003)
    “…Methods: The 22q13 deletion syndrome (MIM 606232) is characterised by moderate to profound mental retardation, delay/absence of expressive speech, hypotonia,…”
    Get full text
    Journal Article
  3. 3

    Classification of BRCA1 missense variants of unknown clinical significance by Phelan, C M, Đapić, V, Tice, B, Favis, R, Kwan, E, Barany, F, Manoukian, S, Radice, P, van der Luijt, R B, van Nesselrooij, B P M, Chenevix-Trench, G, Caldes, T, de La Hoya, M, Lindquist, S, Tavtigian, S V, Goldgar, D, Borg, Å, Narod, S A, Monteiro, A N A

    Published in Journal of medical genetics (01-02-2005)
    “…Background:BRCA1 is a tumour suppressor with pleiotropic actions. Germline mutations in BRCA1 are responsible for a large proportion of breast–ovarian cancer…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas by Ruttledge, Martin H, Sarrazin, Julie, Rangaratnam, Shyam, Phelan, Catherine M, Twist, Elspeth, Merel, Philippe, Delattre, Olivier, Thomas, Gilles, Nordenskjöld, Magnus, Collins, V. Peter, Dumanski, Jan P, Rouleau, Guy A

    Published in Nature genetics (01-02-1994)
    “…Meningiomas are common central nervous system tumours which present usually in the 4th and 5th decades of life. Loss of constitutional heterozygosity on…”
    Get full text
    Journal Article
  6. 6

    Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease by Ruttledge, M H, Andermann, A A, Phelan, C M, Claudio, J O, Han, F Y, Chretien, N, Rangaratnam, S, MacCollin, M, Short, P, Parry, D, Michels, V, Riccardi, V M, Weksberg, R, Kitamura, K, Bradburn, J M, Hall, B D, Propping, P, Rouleau, G A

    Published in American journal of human genetics (01-08-1996)
    “…The gene predisposing to neurofibromatosis type 2 (NF2) on human chromosome 22 has revealed a wide variety of different mutations in NF2 individuals. These…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Absence of constitutional H2AX gene mutations in 101 hereditary breast cancer families by Monteiro, A N A, Zhang, S, Phelan, C M, Narod, S A

    Published in Journal of medical genetics (01-04-2003)
    “…Germline mutations in BRCA1 and BRCA2 increase sensitivity to DNA damage and decrease cellular capacity to repair double strand DNA breaks through homologous…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome by MCCONKIE-ROSELL, A, LACHIEWICZ, A. M, SPIRIDIGLIOZZI, G. A, TARLETON, J, SCHOENWALD, S, PHELAN, M. C, PONMANI GOONEWARDENA, XIAOHUA DING, BROWN, W. T

    Published in American journal of human genetics (01-10-1993)
    “…DNA at the FMR-1 locus was analyzed by Southern blot using probe StB12.3 in an unusual fragile X family with six brothers, three of whom are affected with…”
    Get full text
    Journal Article
  11. 11

    Vascular steal: the pathogenetic mechanism producing sirenomelia and associated defects of the viscera and soft tissues by STEVENSON, R. E, LYONS JONES, K, PHELAN, M. C, JONES, M. C, BARR, M. JR, CLERICUZIO, C, HARLEY, R. A, BENIRSCHKE, K

    Published in Pediatrics (Evanston) (01-09-1986)
    “…Dissection of the abdominal vasculature in 11 cases of sirenomelia has demonstrated a pattern of vascular abnormalities that explains the defects usually found…”
    Get full text
    Journal Article
  12. 12

    DNA methylation analysis with respect to prenatal diagnosis of the Angelman and Prader-Willi syndromes and imprinting by Glenn, Christopher C., Deng, Glenn, Michaelis, Ron C., Tarleton, Jack, Phelan, Mary C., Surh, Linda, Yang, Thomas P., Driscoll, Daniel J.

    Published in Prenatal diagnosis (01-04-2000)
    “…The Angelman (AS) and Prader–Willi syndromes (PWS) are clinically distinct neurobehavioural syndromes resulting from loss of maternal (AS) or paternal…”
    Get full text
    Journal Article
  13. 13

    A deletion in the long arm of chromosome 18 in a child with serum carnosinase deficiency by WILLI, S. M, ZHANG, Y, HILL, J. B, PHELAN, M. C, MICHAELIS, R. C, HOLDEN, K. R

    Published in Pediatric research (01-02-1997)
    “…The dipeptides carnosine and anserine, found exclusively in meats, are hydrolyzed in serum by the enzyme carnosinase. Several reports of serum carnosinase…”
    Get full text
    Journal Article
  14. 14

    Vascular anastomoses leading to amelia and cutis aplasia in a dizygotic twin pregnancy by Phelan, Mary C, Geer, Joseph S, Blackburn, Will R

    Published in Clinical genetics (01-02-1998)
    “…Dichorionic placentation is observed in both monozygotic (MZ) and dizygotic (DZ) twinning, while monochorionic placentation is unique to MZ twinning…”
    Get full text
    Journal Article
  15. 15

    The Human Mammary-Derived Growth Inhibitor (MDGI) Gene: Genomic Structure and Mutation Analysis in Human Breast Tumors by Phelan, Catherine M., Larsson, Catharina, Baird, Stephen, Futreal, P.Andrew, Ruttledge, M.H., Morgan, Kenneth, Tonin, Patricia, Hung, Huynh, Korneluk, Robert G., Pollak, Michael N., Narod, Steven A.

    Published in Genomics (San Diego, Calif.) (15-05-1996)
    “…The mammary-derived growth inhibitor (MDGI) gene is a candidate tumor suppressor gene for human breast cancer. It has been shown to reduce the tumorigenicity…”
    Get full text
    Journal Article
  16. 16

    Detection of submicroscopic deletions in band 17p13 in patients with the Miller-Dieker syndrome by SCHWARTZ, C. E, JOHNSON, J. P, FLANNERY, D. B, STEVENSON, R. E, HOLYCROSS, B, MANDEVILLE, T. M, SEARS, T. S, GRAUL, E. A, CAREY, J. C, SCHROER, R. J, PHELAN, M. C, SZOLLAR, J

    Published in American journal of human genetics (01-11-1988)
    “…The Miller-Dieker syndrome (MDS), a syndrome with lissencephaly, distinctive craniofacial features, growth impairment, and profound developmental failure, has…”
    Get full text
    Journal Article
  17. 17

    Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours by PHELAN, C. M, LU LIU, RUTTLEDGE, M. H, MÜNTZNING, K, RIDDERHEIM, P.-A, COLLINS, V. P

    Published in Human genetics (01-12-1995)
    “…Central nervous system (CNS) tumours are the most common solid tumours in children. Cytogenetic and molecular genetic studies of these neoplasms have…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Vascular basis for neural tube defects: a hypothesis by STEVENSON, R. E, KELLY, J. C, AYLSWORTH, A. S, PHELAN, M. C

    Published in Pediatrics (Evanston) (01-07-1987)
    “…A hypothesis is set forth that neural tube defects are produced by inadequate nutrient supply to the rapidly growing neural folds. According to this…”
    Get full text
    Journal Article
  20. 20